Multidrug-resistant tuberculosis in HIV-negative patients in Lagos, Nigeria

Iwalokun Bamidele O.
Molecular Biology and Biotechnology Department, Nigerian Institute of Medical Research, Lagos, Nigeria.
Search for this author on:
Google Scholar

Igbasi Uche T.

Igbasi Uche T.
Centre for Infectious Disease Research, Nigerian Institute of Medical Research, Lagos, Nigeria.
Search for this author on:
Google Scholar

Onyejepu Nneka

Onyejepu Nneka
Centre for Tuberculosis Research, Nigerian Institute of Medical Research, Lagos, Nigeria.
Search for this author on:
Google Scholar

Ndubuisi Ifeanyi T.

Ndubuisi Ifeanyi T.
Centre for Tuberculosis Research, Nigerian Institute of Medical Research, Lagos, Nigeria.
Search for this author on:
Google Scholar

Tochukwu Nwanneka E.

Tochukwu Nwanneka E.
Centre for Tuberculosis Research, Nigerian Institute of Medical Research, Lagos, Nigeria.
Search for this author on:
Google Scholar

Adedeji Abimbola M.

Adedeji Abimbola M.
Monitoring and Evaluation Unit, Nigerian Institute of Medical Research, Lagos, Nigeria.
Search for this author on:
Google Scholar

Onwujekwe Daniel I.

Onwujekwe Daniel I.
Clinical Science Department, Nigerian Institute of Medical Research, Lagos, Nigeria.
Search for this author on:
Google Scholar

Ezechi Oliver C.

Ezechi Oliver C.
Clinical Science Department, Nigerian Institute of Medical Research, Lagos, Nigeria.
Search for this author on:
Google Scholar

Odunukwe Nkiruka N.

Odunukwe Nkiruka N.
Clinical Science Department, Nigerian Institute of Medical Research, Lagos, Nigeria.
Search for this author on:
Google Scholar

Iyke-Azike Obioma G.

Iyke-Azike Obioma G.
Centre for Tuberculosis Research, Nigerian Institute of Medical Research, Lagos, Nigeria.
Search for this author on:
Google Scholar

Onubogu Catherine C.

Onubogu Catherine C.
Centre for Tuberculosis Research, Nigerian Institute of Medical Research, Lagos, Nigeria.
Search for this author on:
Google Scholar

Article Number - 471B67A65462
Vol.12(2), pp. 12-19 , July 2020
https://doi.org/10.5897/JBR2020.0319

Received: 14 July 2020
Accepted: 30 October 2020
Published: 30 November 2020

References

Abdulazeez AA, Margaret AA, Sulaiman NA, Abdulazeez AI (2019). Multiple-drug resistant (MDR) tuberculosis among HIV sero-positive and sero-negative populations in Ilorin, North-Central Nigeria. South Sudan Medical Journal 12(3):93-96.

Adebisi YA, Agumage I, Sylvanus TD, Nawaila IJ, Ekwere WA, Nasiru M, Okon EE, Ekpenyong AM, Lucero-Prisno DE (2019). Burden of Tuberculosis and Challenges Facing Its Eradication inWest Africa. International Journal of Infection 6(3):e92250. Crossref

Adejumo OA, Olusola-Faleye B, Adepoju VA, Gidado M, Onoh MO, Adegboye O, Razzaq HA, Moronfolu O, Shogbamimu Y (2020a). The pattern of comorbidity and its prevalence among drug-resistant tuberculosis patients at treatment initiation in Lagos, Nigeria. Transactions of the Royal Society of Tropical Medicine and Hygiene 00:1-9. Crossref

Adejumo OA, Daniel OJ, Adepoju VA, Femi-Adebayo T, Adebayo BI, Airauhi AO (2020b). Challenges of tuberculosis control in Lagos State, Nigeria: A qualitative study of health-care providers' perspectives. Nigerian Medical Journal 61(1):37-41. Crossref

Dagora AY, Miaga KD, Adjoh K, Kadanga E, Disse K, Adekambi T (2015). Prevalence of multidrug-resistant tuberculosis cases among HIV-positive and HIV-negative patients eligible for retreatment regimen in Togo using GeneXpert MTB/RIF. New Microbe and New Infections 8:24-27. Crossref

Demile B, Zenebu A, Shewaye H, Xia S, Guadie A (2018). Risk factors associated with multidrug resistant tuberculosis (MDR-TB) in a tertiary armed force referral and teaching hospital, Ethiopia. BMC Infectious Diseases 18:249. Crossref

Dinic L, Akande P, Idigbe EO, Ani A, Onwujekwe D, Agbaji O, Akanbi M, Nwosu R, Adeniyi B, Wahab M, Lekuk C, Kunle-Ope CN, Nwokoye N, Kanki P (2012). Genetic Determinant of Drug-Resistant Tuberculosis among HIV-Infected Patients in Nigeria. Journal of Clinical Microbiology 50(9):2905-2909. Crossref

Ehsanul Huq KATM, Moriyama M, Zaman K, Chisti MJ, Long J, Islam A, Hossain S, Shiri H, Raiha MJ, Chowdhury S, Rahman MM (2018). Health seeking behaviour and delayed management of tuberculosis patients in rural Bangladesh. BMC Infectious Diseases 18:515-523. Crossref

Fadeyi A, Desalu OO, Ugwuoke C, Opanwa OA, Nwabuisi C, Salami AK (2017). Prevalence of rifampicin-resistant tuberculosis among patients previously treated for pulmonary tuberculosis in North-Western, Nigeria. Nigerian Medical Journal 58:161-166. Crossref

Fenner L, Gagneux S, Janssens J, Fehr J, Cavassini M, Hoffman M, Bernasconi E, Schrenzel J, Bodmer T, Bottger EC, Helbling P, Egger M (2012). Tuberculosis in HIV-negative and HIV-infected patients in a low-incidence country: Clinical characterisitics and treatment outcomes. PLoS ONE 7(3):e34186. Crossref

Gehre F, Otu J, Kendall L, Forson A, Kwara A, Kudzawu S, Kehinde OA, Adebiyi O, Salako K, Baldeh I, Jallow A, Jallow M, Dagnra A, Dissé K, Kadanga EA, Idigbe EO, Onubogu C, Onyejepu N, Gaye-Diallo A, Ba-Diallo A, Rabna P, Mane M, Sanogo M, Diarra B, Dezemon Z, Sanou A, Senghore M, Kwambana-Adams BA, Demba E, Faal-Jawara T, Kumar S, Tientcheu LD, Jallow A, Ceesay S, Adetifa I, Jaye A, Pallen MJ, D'Alessandro U, Kampmann B, Adegbola RA, Mboup S, Corrah T, de Jong BC, Antonio M (2016).

The emerging threat of pre-extensively drug-resistant tuberculosis in West Africa: preparing for large-scale tuberculosis research and drug resistance surveillance. BMC Medicine 14:160.

Kent PT, Kubica GP (1985). A Guide for the Level III Laboratory.

Mohammad AB, Iliyasu G, Habib AG (2017). Prevalence and genetic determinant of drug-resistant tuberculosis among patients completing intensive phase of treatment in a Tertiary Referral Center in Nigeria. International Journal Mycobacteriology 6:47-51. Crossref

Mulu W, Mikonnen D, Yimer M, Admassu A, Abera B (2015). Risk factors for multidrug resistant tuberculosis patients in Amhara National Region State. African Health Sciences 15(2):368-377. Crossref

O'Donnell MRO, Daftary A, Frick M, Hirsch-Moverman Y, Amico KR, Senthilingam M, Wolf A, Metcalfe JZ, Isaakidis P, Davis JL, Zelnick JR, Brust JCM, Naidu N, Garretson M, Bangsberg DR, Padayatchi N, Friedland G (2016). Re-inventing Adherece: towards a patient-centered model of care for drug-resistant tuberculosis and HIV. International Journal Tuberculosis Lung Disease 20(4):430-434.

Ogbo FA, Ogeleka P, Okoro A, Olusanya BO, Olusanya J, Ifegwu IK, Awosemo AO, Eastwood J, Page A (2018). Tuberculosis disease burden and attributable risk factors in Nigeria, 1990 - 2016. Tropical Medicine and Health 46:34. Crossref

Okoro CE, Ibhawaegbele SO, Ezema CI, Ezeugwu UA, Igweagu CP, Dozie Nwakile OC (2019). Prevalence of multi-drug-resistant tuberculosis among human immunodeficiency virus and nonhuman immunodeficiency virus-positive pulmonary tuberculosis patients of two referral hospitals in Southeast Nigeria. Ibnosina Journal of Medicine and Biomedical Sciences 11:111-115.

Olowe OA, Makanjuola O, Adekanmi AS, Adefioye OJ, Olowe RA (2017). Epidemiological characteristics and clinical outcome of HIV-related tuberculosis in a population of TB patients in South-Western Nigeria. European Journal of Microbiology and Immunology 7(2):127-132. Crossref

Onyedum CC, Alobu I, Ukwaja KN (2017). Prevalence of drug-resistant tuberculosis in Nigeria: A systematic review and meta-analysis. PLoS ONE 12(7):e0180996. Crossref

Otokunefor K, Otokunefor TV, Omakwele G (2018). Multi-drug resistant Mycobacterium tuberculosis in Port Harcourt, Nigeria. African Journal of Laboratory Medicine 7(2):805.

Pokam BT, Asuquo AE, Abia-Bassey LN, Idasa MB, Umoh NO, Eko FO, Rastogi N (2013). Multidrug resistance and demography of newly diagnosed tuberculosis patients in Cross River State, Nigeria. International Journal of Mycobacteriology 2:89-93. Crossref

Saldanha N, Runwal K, Ghanekar C, Gaikwad S, Sane S, Pujari S (2019). High prevalence of multi drug resistant tuberculosis in people living with HIV in Western India. BMC Infectious Diseases 19:391-396. Crossref

Samuels JP, Soods A, Campbell JR, Khan FA, James, Johnston C (2018). Comorbidities and treatment outcomes in multidrug resistant tuberculosis: a systematic review and meta-analysis. Scientific Reports 8:4980. Crossref

Sanchez-Padilla E, Diamini T, Ascorra A, Rush-Gerdes S, Tefera ZD, Calain P, de la Tour R, Jochims F, Richter E, Bonnet M (2012). High Prevalence of Multidrug-Resistant Tuberculosis, Swaiziland. Emerging Infectious Diseases 18(1):29-37. Crossref

Wang M, Huang W, Wang Y, Zhang Y, Zhang M, Wu S, Sandford AJ, He J (2018). Association between tobacco smoking and drug-resistant tuberculosis. Infection and Drug Resistance 11:873-887. Crossref

World Health Organization, Global Tuberculosis Control: WHO Report 2017, WHO, Geneva, Switzerland.

Yeboah-Manu D, Asante-Poku A, Ampah KA, Kpeli G, Danso E, Owusu-Darko K, Bonsu FA (2012). Drug susceptibility pattern of Mycobacterium tuberculosis isolates from Ghana; Correlation with Clinical Response. Mycobacacterial Disease 2:107.